167 related articles for article (PubMed ID: 984787)
1. Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis.
Ahern MJ; Finkelstein FO; Andriole VT
Antimicrob Agents Chemother; 1976 Sep; 10(3):457-61. PubMed ID: 984787
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of cefamandole in patients with renal failure.
Meyers BR; Hirschman SZ
Antimicrob Agents Chemother; 1977 Feb; 11(2):248-50. PubMed ID: 848929
[TBL] [Abstract][Full Text] [Related]
3. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of cefamandole in the presence of renal failure in patients undergoing hemodialysis.
Appel GB; Neu HC; Parry MF; Goldberger MJ; Jacob GB
Antimicrob Agents Chemother; 1976 Oct; 10(4):623-5. PubMed ID: 984799
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of cefamandole in patients with renal impairment.
Czerwinski AW; Pederson JA
Antimicrob Agents Chemother; 1979 Feb; 15(2):161-4. PubMed ID: 426510
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of cephalosporins in patients with normal or reduced renal function.
Andriole VT
J Infect Dis; 1978 May; 137 Suppl():S88-S99. PubMed ID: 349098
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of ceforanide in patients with end stage renal disease on hemodialysis.
Hess JR; Berman SJ; Boughton WH; Sugihara JG; Musgrave JE; Wong EG; Siemsen AM
Antimicrob Agents Chemother; 1980 Feb; 17(2):251-3. PubMed ID: 7387145
[TBL] [Abstract][Full Text] [Related]
8. Cefamandole pharmacokinetics and dosage adjustments in relation to renal function.
Brogard JM; Kopferschmitt J; Spach MO; Grudet O; Lavillaureix J
J Clin Pharmacol; 1979 Jul; 19(7):366-77. PubMed ID: 479381
[TBL] [Abstract][Full Text] [Related]
9. Hydrolysis of cefamandole nafate in dialysis patients.
Nielsen RL; Wolen R; Luft FC; Ozawa T
Antimicrob Agents Chemother; 1979 Nov; 16(5):683-5. PubMed ID: 526012
[TBL] [Abstract][Full Text] [Related]
10. Effects of renal failure and dialysis on cefazolin pharmacokinetics.
Madhavan T; Yaremchuk K; Levin N; Fisher E; Cox F; Burch K; Haas E; Pohlod D; Quinn EL
Antimicrob Agents Chemother; 1975 Jul; 8(1):63-6. PubMed ID: 1164008
[TBL] [Abstract][Full Text] [Related]
11. Cefamandole kinetics in uremic patients undergoing hemodialysis.
Gambertoglio JG; Aziz NS; Lin ET; Grausz H; Naughton JL; Benet LZ
Clin Pharmacol Ther; 1979 Nov; 26(5):592-9. PubMed ID: 498702
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics of theophylline in peritoneal dialysis and hemodialysis.
Lee CS; Peterson JC; Marbury TC
J Clin Pharmacol; 1983 Jul; 23(7):274-80. PubMed ID: 6886029
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics of cefamandole, cephapirin, and cephalothin in healthy subjects and effect of repeated dosing.
Barza M; Melethil S; Berger S; Ernst EC
Antimicrob Agents Chemother; 1976 Sep; 10(3):421-5. PubMed ID: 984783
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of ceftazidime in patients undergoing peritoneal dialysis.
Tourkantonis A; Nicolaidis P
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():263-7. PubMed ID: 6352629
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.
Neu HC
J Infect Dis; 1978 May; 137 Suppl():S80-S87. PubMed ID: 650006
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cefamandole in patients undergoing hemodialysis.
Campillo JA; Lanao JM; Dominguez-Gil A; Tabernero JM; Rubio F
Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):416-20. PubMed ID: 500264
[TBL] [Abstract][Full Text] [Related]
17. The pharmacology of cefamandole in patients with reduced renal function.
Czerwinski AW; Pederson JA
Scand J Infect Dis Suppl; 1980; suppl 25():45-8. PubMed ID: 6937951
[TBL] [Abstract][Full Text] [Related]
18. Disposition kinetics of cefamandole during continuous ambulatory peritoneal dialysis.
Bliss M; Mayersohn M; Arnold T; Logan J; Michael UF; Jones W
Antimicrob Agents Chemother; 1986 Apr; 29(4):649-53. PubMed ID: 3707113
[TBL] [Abstract][Full Text] [Related]
19. Effect of peritoneal dialysis on serum levels of tobramycin and clindamycin.
Malacoff RF; Finkelstein FO; Andriole VT
Antimicrob Agents Chemother; 1975 Nov; 8(5):574-80. PubMed ID: 1211913
[TBL] [Abstract][Full Text] [Related]
20. Moxalactam pharmacokinetics during hemodialysis.
Aronoff GR; Sloan RS; Mong SA; Luft FC; Kleit SA
Antimicrob Agents Chemother; 1981 Apr; 19(4):575-7. PubMed ID: 6454386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
